Nemesis Bioscience (AgeTech UK) Covid-19
Novel antibiotics. Nemesis Bioscience is a new biopharmaceutical company developing Nemesis Symbiotics© - DNA therapeutics administered before antibiotics to inactivate resistance in bacterial pathogens.
Technology:
AgeTech Companies
Industry:
UK AgeTech 2020
Headquarters:
United Kingdom
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership